Evidence map›Paper›PMID 39601552›Full record

ArticlemSphere2024

Ryosuke Yamamoto, Yui Tanaka, Shunsuke Orii, Kogiku Shiba, Kazuo Inaba, Takahide Kon

Abstract read
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryosuke Yamamoto *Department of Biological Sciences, Graduate School of Science, Osaka University, Osaka, Japan.ORCID 0000-0002-5282-2343
Yui Tanaka *Department of Biological Sciences, Graduate School of Science, Osaka University, Osaka, Japan.
Shunsuke OriiDepartment of Biological Sciences, Graduate School of Science, Osaka University, Osaka, Japan.
Kogiku ShibaShimoda Marine Research Center, University of Tsukuba, Shizuoka, Japan.ORCID 0000-0002-7742-8158
Kazuo InabaShimoda Marine Research Center, University of Tsukuba, Shizuoka, Japan.ORCID 0000-0001-8848-9733
Takahide KonDepartment of Biological Sciences, Graduate School of Science, Osaka University, Osaka, Japan.ORCID 0000-0002-1231-7609

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motile flagella (also called "motile cilia") play a variety of important roles in lower and higher eukaryotes, including cellular motility and fertility. Flagellar motility is driven by several species of the gigantic motor-protein complexes, flagellar dyneins, that reside within these organelles. Among the flagellar-dynein species, a hetero-dimeric dynein called "IDA f/I1" has been shown to be particularly important in controlling the flagellar waveform, and defects in this dynein species in humans cause ciliopathies such as multiple morphological abnormalities of the flagella and asthenoteratozoospermia. IDA f/I1 is composed of many subunits, including two HCs (HCα and HCβ) and three ICs (IC140, IC138, and IC97), and among the three ICs of IDA f/I1, the exact molecular function(s) of IC97 in flagellar motility is not well understood. In this study, we isolated a IMPORTANCE: IDA f/I1 is a hetero-dimeric flagellar dynein that is particularly important for the regulation of flagellar waveform and whose defects are associated with human ciliopathies. IC97 is an evolutionarily conserved intermediate chain of IDA f/I1, but the detailed molecular functions of IC97 in flagellar motility have not been elucidated. In this study, mutational and biochemical analyses of the previously uncharacterized

Indexed as

DyneinsFlagellaCell MovementChlamydomonasChlamydomonas reinhardtiiMutationDyneinsCASC1 (LAS1/CFAP94/DNAI7)Chlamydomonaseukaryotic flagella (cilia)FAP120IC97 (DII6/FAP94)IDA f/I1

Identifiers

PMID39601552
PMCPMC11656769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.